Alps Group Inc (ALPS) vs Gain Therapeutics, Inc. (GANX)
A side-by-side comparison of Alps Group Inc and Gain Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALPS
Alps Group Inc
$0.40HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GANX
Gain Therapeutics, Inc.
$1.69HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALPS vs GANX
growth of $100 · dividends reinvested · last 1yALPS -96.7% (-96.7%/yr)GANX -13.3% (-13.3%/yr)GANX compounded faster over this window
Log scale — wide-divergence pair
ALPS GANX
ALPS vs GANX: by the numbers
- •GANX is the larger company ($72M vs $67M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -41.36% net margin).
Metrics side by side
Valuation
| Metric | ALPS | GANX |
|---|---|---|
| P/B ratio | N/A | 6.38 |
Profitability
| Metric | ALPS | GANX |
|---|---|---|
| Gross margin | 32.09% | 0.00% |
| Operating margin | -69.62% | 0.00% |
| Net margin | -41.36% | 0.00% |
| ROE | N/A | -178.06% |
| ROIC | N/A | -159.24% |
Growth (annualized)
| Metric | ALPS | GANX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -25.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.